文献速递鼻科

多组学孟德尔随机化揭示POR为慢性鼻窦炎伴鼻息肉潜在治疗靶点

[Mendelian randomization analysis integrating genomics and proteomics reveals cytochrome P450 oxidoreductase as a potential target for the treatment of chronic rhinosinusitis with nasal polyps].
PubMed 文献 · Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi · 2026-01-01

本研究通过整合基因组学与蛋白组学的孟德尔随机化分析,结合30例CRSwNP患者和30例对照的临床样本及体外实验,发现细胞色素P450氧化还原酶(POR)与CRSwNP风险呈负相关,且患者外周血和鼻息肉组织中POR蛋白表达下调,体外实验提示POR可能通过抑制NF-κB通路影响炎症微环境。

要点

  • POR与CRSwNP风险呈负相关,发现队列OR=0.87,复制队列OR=0.82。
  • CRSwNP患者外周血和鼻息肉组织中POR蛋白表达均下调(P<0.01)。
  • 体外实验提示POR可能抑制NF-κB通路激活。

核心结论

  • 多组学MR分析提示POR是CRSwNP的潜在治疗靶点,可能通过调控NF-κB通路影响炎症微环境。

研究设计与样本

  • 采用MR、基于汇总数据的MR(SMR)及共定位分析,从基因和蛋白水平筛选靶点。
  • cis-eQTL来自eQTLGen数据库,cis-pQTL来自deCODE数据库,CRSwNP遗传数据来自FinnGen和IEU数据库。
  • 纳入30例CRSwNP患者和30例鼻中隔偏曲对照,检测外周血及鼻息肉组织目标靶点表达。
  • 采用人RPMI 2650细胞系进行体外实验探索机制。

主要发现

  • MR分析显示POR与CRSwNP风险显著负相关(发现队列:OR=0.87,P=1.47×10-5;复制队列:OR=0.82,P=1.09×10-7)。
  • cis-pQTL-MR分析进一步支持该关联(OR=0.77,P=4.12×10-4)。
  • CRSwNP患者外周血和鼻息肉组织中POR蛋白表达均下调(P<0.01)。
  • 体外实验提示POR可能抑制NF-κB通路激活。

临床怎么用

  • POR可能作为CRSwNP的潜在治疗靶点,其作用机制可能与调控NF-κB通路相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore potential therapeutic targets for chronic rhinosinusitis with nasal polyps (CRSwNP) through Mendelian randomization (MR) analysis integrating genomics and proteomics. Methods: Potential therapeutic targets were identified at the gene expression and protein levels using MR, summary-data-based Mendelian randomization (SMR), and colocalization analysis. Cis-eQTLs from the eQTLGen database and cis-pQTLs from the deCODE database were used as instrumental variables to validate targets at the gene expression and protein levels, respectively. Genetic data for CRSwNP were obtained from the FinnGen database and the IEU database. Thirty patients with CRSwNP and 30 patients with nasal septal deviation as the control group who were treated at the Second Affiliated Hospital of Harbin Medical University from September 2024 to September 2025 were enrolled in the study to detect the expression levels of target genes in the peripheral blood and nasal polyp tissue of CRSwNP patients, including 33 males and 27 females, aged 22 to 59 years old. In vitro experiments were conducted using the human RPMI 2650 cell line to preliminarily explore the potential mechanisms of action of the target genes. GraphPad Prism 9.0 was used for statistical analysis. Results: MR analysis revealed a significant negative association between cytochrome P450 oxidoreductase (POR) and CRSwNP risk (discovery cohort: OR=0.87, P=1.47×10-5; replication cohort: OR=0.82, P=1.09×10-7); cis-pQTL-MR analysis further supported this association (OR=0.77, P=4.12×10-4). POR protein expression was downregulated in both peripheral blood and polyp tissue from CRSwNP patients (P<0.01 for all comparisons). In vitro experiments suggested that POR may inhibit activation of the NF-κB pathway. Conclusion: Mult-omics MR analysis suggests that POR is a potential therapeutic target for CRSwNP, and it may influence the inflammatory microenvironment by regulating the NF-κB pathway. 目的: 通过整合基因组学与蛋白组学的孟德尔随机化(MR)分析,探索慢性鼻窦炎伴鼻息肉(CRSwNP)的潜在治疗靶点。 方法: 通过MR、基于汇总数据的MR(SMR)及共定位分析,分别从基因和蛋白水平筛选潜在治疗靶点。在基因和蛋白水平验证靶点的工具变量分别是eQTLGen数据库的顺式基因表达数量性状位点(cis-eQTL)和deCODE数据库的顺式蛋白质数量性状位点(cis-pQTL),CRSwNP的遗传数据来自芬兰数据库和IEU数据库。纳入2024年9月至2025年9月于哈尔滨医科大学附属第二医院就诊的30例CRSwNP患者和30例鼻中隔偏曲患者(对照组),其中男33例,女27例,年龄22~59岁,以检测CRSwNP患者外周血及鼻息肉组织中目标靶点的表达水平。采用人RPMI2650细胞系进行体外实验,对目标靶点的潜在作用机制进行初步探索。采用GraphPad Prism 9.0进行统计学分析。 结果: MR分析显示,细胞色素P450氧化还原酶(POR)与CRSwNP风险呈负相关(发现队列:OR=0.87,P=1.47×10-5;复制队列:OR=0.82,P=1.09×10-7);pQTL-MR进一步支持该关联(OR=0.77,P=4.12×10-4)。CRSwNP患者外周血和鼻息肉组织中POR蛋白表达均下调(P值均<0.01)。体外实验提示POR可能抑制核因子κB(NF-κB)通路激活。 结论: 多组学MR分析提示,POR是CRSwNP的潜在治疗靶点,其作用可能通过调控NF-κB通路影响炎症微环境。.

来源:Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhang FS, Xu ZN, Yan BR, et al. [Mendelian randomization analysis integrating genomics and proteomics reveals cytochrome P450 oxidoreductase as a potential target for the treatment of chronic rhinosinusitis with nasal polyps]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2026. PMID: 42811552. doi:10.3760/cma.j.cn115330-20260218-00104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。